Navigation Links
Study raises questions about use of anti-epilepsy drugs in newborns
Date:5/11/2012

a reexamination of the use of these drugs in infants, and our findings provide experimental data to support that need," says the study's co-lead investigator, Patrick A. Forcelli, Ph.D., a postdoctoral fellow in the department of pharmacology and physiology at GUMC. "Phenobarbital has been used to treat seizures for over 100 years -- well before a Food and Drug Administration approval process was established-- and for more than 50 years, it has been the first drug of choice in the treatment of seizures in neonates."

According to the Epilepsy Foundation, epilepsy affects more than 300,000 Americans under the age of 15. Seizures in neonates are relatively common, and seizure incidence peaks in the first year of life and remains at a high level up to age four.

Recent studies of IQ and other measurements of cognitive function in children have suggested that exposure to certain anti-epilepsy drugs, either in utero or infancy, affects brain function, but the issue is highly controversial, Forcelli says.

"Seizures do not happen to a normal healthy brain," he says. "They are typically associated with, or are a result of, an injury or another neurological condition. So the issue is: what causes later deficits in function -- the underlying condition, the seizures, or the drug used to treat the seizures or some combination of these? Our study in otherwise normal animals suggests that drugs by themselves can be a significant factor."

The Georgetown researchers say their study was designed to look directly at the effect of the different drugs on normal growth of brain neural networks in otherwise normal animals.

This kind of study can only with research in animals, in which each component (condition, seizure and drug) can be controlled and examined separately and in combination.

This kind of study can only be performed in animal models, in which the drug effects can be examined separately from the effects of either seizu
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. £2 million study to reveal workings of dementia genes
3. New study looks to define evangelicals and how they affect polling
4. CU-Boulder study suggests air quality regulations miss key pollutants
5. Researchers study acoustic communication in deep-sea fish
6. Study reveals homeowner perceptions in fire-prone areas
7. Researchers study how pistachios may improve heart health
8. Study: urban black bears live fast, die young
9. New study indicates link between weight gains during pregnancy and dieting history
10. Study reveals specific gene in adolescent men with delinquent peers
11. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2014)... up, and you cannot lift your upper eyelid. You walk ... eyes look straight when they are rolled down in the ... allow people a normal position of their head. In order ... this happens. , In a paper published in the April ... of Iowa researchers Bernd Fritzsch and Jeremy Duncan and their ...
(Date:4/16/2014)... Adam Arkin, director of the Physical Biosciences Division ... a biologist who is recognized as a leading ... networks and populations and their application to systems ... six recipients of the 2013 Ernest Orlando Lawrence ... E.O. Lawrence Award, the Department of Energy (DOE),s ...
(Date:4/16/2014)... Aktories and Dr. Panagiotis Papatheodorou from the Institute of ... of Freiburg have discovered the receptor responsible for smuggling ... into the cell. The TpeL toxin, which is formed ... gas gangrene and food poisoning. It is very similar ... the genus Clostridium . The toxins bind to ...
Breaking Biology News(10 mins):Researchers track down cause of eye mobility disorder 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Gate for bacterial toxins found 2
... give the Anne McLaren Memorial Lecture at the UK National Stem ... to screening for drugs that target stem cells. To begin with, ... for new drugs to promote wound healing and aid the use ... can also be applied to a wide range of stem cells, ...
... food source, with a global harvest now at 110 million ... But epidemics of infectious disease threaten this vital industry, including ... Perhaps even more worrisome: these infections can spread to wild ... escaping from them. Heart and skeletal muscle ...
... nanotechnology in the field of drug delivery has attracted ... holds great promise for the development of targeted, localized ... are affected. Such targeted-therapy methods would ... anticancer drugs are distributed throughout the body, attacking healthy ...
Cached Biology News:Top professor will report new way to discover drugs that aid regenerative medicine 2New virus may pose risk to wild salmon 2Researchers use nanoparticles to shrink tumors in mice 2Researchers use nanoparticles to shrink tumors in mice 3
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... has initiated coverage of Alliqua, Inc. (OTCQB: ALQA). ... manufacturing, and marketing proprietary products to serve the ... http://equitiesiq.com/reports/alliqua/ , In late 2012, Alliqua was ... which launched the company’s new strategy to become ...
(Date:1/14/2014)... 2014 In recent years, growing ... and methods in product development and promotion has ... the industry. This mistrust, fueled by concerns about ... been further fed by reports of spectacular fines ... activities, allegations of industry suppression of negative clinical ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ... said Dr. Andrew Brown, SPIE Senior Director for Global ...
(Date:1/14/2014)... 2014 BioMedomics, Inc. , a ... POC diagnostic platforms and novel disease specific POC tests, ... round of financing netting a total of $690,000. The ... outside equity capital in the company. This group of ... in diagnostics companies and includes Tom Roberg who was ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... the Trudeau Institute may help to explain why live ... protection. The research is published in this month,s ... entitled "Live attenuated influenza vaccine (LAIV) impacts innate and ... scientist Dr. Laura Haynes and her colleagues. "Our ...
... ARBOR, Mich.---A delicate balance of atomic forces can be ... size---an attribute that,s important for many nanotech applications but ... The same type of forces are at work ... inorganic supercluster structures in this research are in many ...
... ST. LOUIS, Aug. 23, 2011 Bunge North America, ... BG ), issued the following statement which can be ... "Bunge North America is aware from press ... prior conversations with Syngenta, we are surprised and disappointed that ...
Cached Biology Technology:Trudeau Institute announces a discovery in how FluMist elicits protection 2Engineers discover nanoscale balancing act that mirrors forces at work in living systems 2Bunge Responds to Syngenta Suit 2